ZBTB20 and gastric cancer: We got similar results and found that there was a significant correlation between ZBTB20 rs9288999 and reducing the gastric cancer risk in participants who are non-smokers (OR = 0.46, P=0.009), non-drinking (OR = 0.54, P=0.035), age ≤ 60 years (OR = 0.33, P=0.0002) and male participants (OR = 0.45, P=0.0005).